Effective inhibition of MERS-CoV infection by resveratrol

BACKGROUND: Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality. Up to date, there is no approved or licensed vaccine or antiviral medicines can be used to treat MERS-CoV-infected patients. Here, we analyzed the antiviral a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shih-Chao, Ho, Chi-Tang, Chuo, Wen-Ho, Li, Shiming, Wang, Tony T., Lin, Chi-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307780/
https://www.ncbi.nlm.nih.gov/pubmed/28193191
http://dx.doi.org/10.1186/s12879-017-2253-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307780/
https://www.ncbi.nlm.nih.gov/pubmed/28193191
http://dx.doi.org/10.1186/s12879-017-2253-8

Ejemplares similares